scholarly article | Q13442814 |
P50 | author | Tomas Bergström | Q39548937 |
Edward Trybala | Q39986541 | ||
P2093 | author name string | Olofsson S | |
Glorioso JC | |||
Jeansson S | |||
Svennerholm B | |||
P407 | language of work or name | English | Q1860 |
P921 | main subject | Herpes simplex virus type 1 | Q655331 |
P304 | page(s) | 743-752 | |
P577 | publication date | 1994-04-01 | |
P1433 | published in | Journal of General Virology | Q6295245 |
P1476 | title | Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate | |
P478 | volume | 75 ( Pt 4) |
Q35831618 | A heterologous heparin-binding domain can promote functional attachment of a pseudorabies virus gC mutant to cell surfaces. |
Q36365234 | Adherence of pilus- Opa+ gonococci to epithelial cells in vitro involves heparan sulfate |
Q34281238 | Amino acid differences in glycoproteins B (gB), C (gC), H (gH) and L (gL) are associated with enhanced herpes simplex virus type-1 (McKrae) entry via the paired immunoglobulin-like type-2 receptor α. |
Q40923636 | Antiherpetic activity and mode of action of natural carrageenans of diverse structural types |
Q24519029 | Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo |
Q40348272 | Antiviral activity of chondroitin sulphate E targeting dengue virus envelope protein |
Q40126963 | Binding Kinetics and Lateral Mobility of HSV-1 on End-Grafted Sulfated Glycosaminoglycans. |
Q37060288 | Blocking Immune Evasion as a Novel Approach for Prevention and Treatment of Herpes Simplex Virus Infection |
Q42013420 | Cell penetration peptides for enhanced entry of αB-crystallin into lens cells |
Q34464575 | Cell surface heparan sulfate and its roles in assisting viral infections |
Q39870279 | Cell surface proteoglycans are not essential for infection by pseudorabies virus. |
Q40228962 | Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins |
Q45739542 | Characterization of strain HSZP of herpes simplex virus type 1 (HSV1). |
Q33327584 | Enhanced nigrostriatal neuron-specific, long-term expression by using neural-specific promoters in combination with targeted gene transfer by modified helper virus-free HSV-1 vector particles |
Q37278750 | Focus on antivirally active sulfated polysaccharides: from structure-activity analysis to clinical evaluation. |
Q39672261 | GapA and CrmA coexpression is essential for Mycoplasma gallisepticum cytadherence and virulence |
Q36194868 | Glycoconjugate glycans as viral receptors |
Q33785801 | Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread |
Q34351333 | Heparan sulfate: anchor for viral intruders? |
Q27485008 | Herpes Simplex Virus Type 2 Glycoprotein G Is Targeted by the Sulfated Oligo- and Polysaccharide Inhibitors of Virus Attachment to Cells |
Q39539848 | Herpes simplex virus types 1 and 2 differ in their interaction with heparan sulfate. |
Q34344174 | Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry |
Q39736541 | Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain |
Q39595322 | Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. |
Q40588204 | Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans |
Q38899213 | Inhibition of herpes simplex virus type 1 infection by cationic beta-peptides |
Q35841977 | Interaction of herpes simplex virus glycoprotein gC with mammalian cell surface molecules |
Q38077470 | Members of 3-O-Sulfotransferases (3-OST) Family: A Valuable Tool from Zebrafish to Humans for Understanding Herpes Simplex Virus Entry |
Q35533138 | Microbial adherence to and invasion through proteoglycans |
Q38854789 | Mucin-like Region of Herpes Simplex Virus Type 1 Attachment Protein Glycoprotein C (gC) Modulates the Virus-Glycosaminoglycan Interaction |
Q33395218 | Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection |
Q40574628 | Novel DL-galactan hybrids from the red seaweed Gymnogongrus torulosus are potent inhibitors of herpes simplex virus and dengue virus |
Q45731678 | Peptides containing membrane-transiting motifs inhibit virus entry |
Q41115170 | Protein-glycosaminoglycan interactions: infectiological aspects |
Q33799437 | Pseudotyping of glycoprotein D-deficient herpes simplex virus type 1 with vesicular stomatitis virus glycoprotein G enables mutant virus attachment and entry |
Q33786002 | Recombinant herpes simplex virus type 1 engineered for targeted binding to erythropoietin receptor-bearing cells. |
Q38950892 | Retargeting of herpes simplex virus (HSV) vectors |
Q38342862 | Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C. |
Q40402866 | Targeted gene transfer to nigrostriatal neurons in the rat brain by helper virus-free HSV-1 vector particles that contain either a chimeric HSV-1 glycoprotein C-GDNF or a gC-BDNF protein |
Q34455165 | Targeting gene expression using HSV vectors |
Q42642478 | The Importance of Heparan Sulfate in Herpesvirus Infection |
Q44497221 | The antiviral activity of naturally occurring proteins and their peptide fragments after chemical modification |
Q42539366 | The antiviral activity of the ribonucleotide reductase inhibitor BILD 1351 SE in combination with acyclovir against HSV type-1 in cell culture |
Q33797437 | The porcine humoral immune response against pseudorabies virus specifically targets attachment sites on glycoprotein gC. |
Q35855824 | The receptor-binding domain of pseudorabies virus glycoprotein gC is composed of multiple discrete units that are functionally redundant |
Q39451283 | Typing of clinical herpes simplex virus type 1 and type 2 isolates with monoclonal antibodies. |
Search more.